PANACEA BIOTEC LTD Intrinsic Value
PANACEABIO · Healthcare · Current price ₹548.85
Is PANACEA BIOTEC LTD undervalued?
DocStoX estimates the fair value of PANACEA BIOTEC LTD at ₹112 per share, versus the current market price of ₹549. That puts the stock about -79.6% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 1 independent method: Residual income (₹112). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹95 (bear) to ₹112 (base) to ₹129 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹549 versus an intrinsic value of ₹112, PANACEA BIOTEC LTD currently offers -79.6% of negative margin (i.e. a premium).
More on PANACEA BIOTEC LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.